Structure Therapeutics › Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure Therapeutics (NASDAQ: GPCR), skyrocketed almost 103% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback